Adults older than 55 years with overweight or obesity, but without type 2 diabetes, who started tirzepatide (Zepbound) had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results